Cytokinetics CYTK Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseOther.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's interest expense?
- Cytokinetics (CYTK) reported interest expense of $14.52M in Q1 2026.
- How has Cytokinetics's interest expense changed year-over-year?
- Cytokinetics's interest expense increased by 63.7% year-over-year, from $8.87M to $14.52M.
- What is the long-term trend for Cytokinetics's interest expense?
- Over 4 years (2021 to 2025), Cytokinetics's interest expense has grown at a 29.0% compound annual growth rate (CAGR), from $16.44M to $45.58M.
- What does interest expense mean?
- The cost of borrowing money.
- How do you interpret interest expense?
- Higher interest expense indicates increased debt levels or higher interest rates, which can pressure cash flow and net income.
- How does interest expense compare across companies?
- Varies significantly based on capital structure and credit rating; biotech firms often have lower debt levels unless they are highly leveraged.